Dexcom, Inc., a leading player in the diabetes care industry, is headquartered in the United States. Founded in 1999, the company has pioneered continuous glucose monitoring (CGM) technology, significantly enhancing diabetes management for patients worldwide. With a strong presence in North America, Europe, and Asia, Dexcom focuses on developing innovative solutions that empower individuals to take control of their health. The company's flagship products, including the Dexcom G6 and G7 CGM systems, offer real-time glucose monitoring with exceptional accuracy and ease of use. These devices are distinguished by their ability to provide users with actionable insights, helping to prevent hypoglycaemic events and improve overall glycaemic control. Dexcom's commitment to innovation has solidified its position as a market leader, recognised for its contributions to diabetes management and patient care.
How does Dexcom's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dexcom's score of 37 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Dexcom reported total greenhouse gas emissions of approximately 30,000,000 kg CO2e, comprising Scope 1 emissions of about 5,000,000 kg CO2e and Scope 2 emissions of approximately 25,000,000 kg CO2e. Additionally, Scope 3 emissions, which include business travel and waste generated in operations, accounted for about 7,000,000 kg CO2e. Dexcom has set ambitious climate commitments, aiming to reduce its greenhouse gas emissions by 30% from a 2022 baseline by the year 2030. This target applies to both Scope 1 and Scope 2 emissions, reflecting the company's commitment to sustainability across its operations and supply chain. The company has consistently disclosed its emissions data across all relevant scopes, demonstrating transparency in its environmental impact. As part of the healthcare equipment and supplies sector, Dexcom's initiatives align with industry standards for climate action, although it has not yet committed to a net-zero target.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 1,903,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 9,371,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | 1,257,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Dexcom is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.